Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients

[1]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[2]  V. Band,et al.  Biochemical characterization of human Ecdysoneless reveals a role in transcriptional regulation , 2010, Biological chemistry.

[3]  V. Band,et al.  Role of Mammalian Ecdysoneless in Cell Cycle Regulation* , 2009, The Journal of Biological Chemistry.

[4]  Debra L Winkeljohn Triple-negative breast cancer. , 2008, Clinical journal of oncology nursing.

[5]  L. Carey,et al.  What is triple-negative breast cancer? , 2008, European journal of cancer.

[6]  J. Sage,et al.  Cellular mechanisms of tumour suppression by the retinoblastoma gene , 2008, Nature Reviews Cancer.

[7]  D. Spandidos,et al.  Human Papilloma Virus (HPV) and Host Cellular Interactions , 2008, Pathology & Oncology Research.

[8]  A. Giordano,et al.  From G0 to S phase: A view of the roles played by the retinoblastoma (Rb) family members in the Rb‐E2F pathway , 2007, Journal of cellular biochemistry.

[9]  Ian O Ellis,et al.  Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  E. Warner,et al.  Screening for hereditary breast cancer. , 2007, Seminars in oncology.

[11]  W. Du,et al.  Retinoblastoma family genes , 2006, Oncogene.

[12]  Sam W. Lee,et al.  The human orthologue of Drosophila ecdysoneless protein interacts with p53 and regulates its function. , 2006, Cancer research.

[13]  J. Robertson,et al.  Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation , 2006, The Journal of pathology.

[14]  M. Barbacid,et al.  Mammalian cyclin-dependent kinases. , 2005, Trends in biochemical sciences.

[15]  G. Ball,et al.  High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses , 2005, International journal of cancer.

[16]  Brian David Dynlacht,et al.  New insights into cyclins, CDKs, and cell cycle control. , 2005, Seminars in cell & developmental biology.

[17]  B. Clurman,et al.  Cyclin E in normal and neoplastic cell cycles , 2005, Oncogene.

[18]  P. Hinds,et al.  Cyclins and cdks in development and cancer: a perspective , 2005, Oncogene.

[19]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[20]  I. Ellis,et al.  The Nottingham prognostic index in primary breast cancer , 2005, Breast Cancer Research and Treatment.

[21]  D. Rimm,et al.  X-Tile , 2004, Clinical Cancer Research.

[22]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.

[23]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[24]  V. Band The role of retinoblastoma and p53 tumor suppressor pathways in human mammary epithelial cell immortalization. , 1998, International journal of oncology.

[25]  C. Sherr Cancer Cell Cycles , 1996, Science.

[26]  L. Hengst,et al.  Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1 , 1995, Molecular and cellular biology.

[27]  David M. Livingston,et al.  Functional interactions of the retinoblastoma protein with mammalian D-type cyclins , 1993, Cell.

[28]  R. Weinberg,et al.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins , 1992, Cell.

[29]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[30]  E B Cox,et al.  Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. , 1985, Archives of pathology & laboratory medicine.